Supernus Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.

CEO

Jack A. Khattar

CEOJack A. Khattar

Employees

674

Employees674

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2005

Founded2005

Employees

674

Employees674

SUPN Key Statistics

Market cap

2.38B

Market cap2.38B

Price-Earnings ratio

32.80

Price-Earnings ratio32.80

Dividend yield

—

Dividend yield—

Average volume

1.14M

Average volume1.14M

High today

$43.62

High today$43.62

Low today

$37.55

Low today$37.55

Open price

$39.15

Open price$39.15

Volume

3.81M

Volume3.81M

52 Week high

$43.62

52 Week high$43.62

52 Week low

$29.16

52 Week low$29.16

SUPN News

Seeking Alpha 1d

Supernus raises 2025 revenue guidance to $670M-$700M following Sage acquisition and strong core product growth

Earnings Call Insights Supernus raises 2025 revenue guidance to $670M-$700M following Sage acquisition and strong core product growth Aug. 05, 2025 6:19 PM ET S...

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.